ES2180703T3 - Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante. - Google Patents

Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante.

Info

Publication number
ES2180703T3
ES2180703T3 ES96303930T ES96303930T ES2180703T3 ES 2180703 T3 ES2180703 T3 ES 2180703T3 ES 96303930 T ES96303930 T ES 96303930T ES 96303930 T ES96303930 T ES 96303930T ES 2180703 T3 ES2180703 T3 ES 2180703T3
Authority
ES
Spain
Prior art keywords
scallene
scalan
mammals
phospholipide
tensioactive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96303930T
Other languages
English (en)
Other versions
ES2180703T5 (es
Inventor
Richard Norman Hjorth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23825442&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2180703(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of ES2180703T3 publication Critical patent/ES2180703T3/es
Application granted granted Critical
Publication of ES2180703T5 publication Critical patent/ES2180703T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTA INVENCION DESCRIBE COMPOSICIONES DE VACUNAS PARA MAMIFEROS QUE CONTIENEN UNA CANTIDAD EFICAZ DE UN ADYUVANTE COMPUESTO POR ESCUALENO O ESCUALANO, UNO O MAS FOSFOLIPIDOS Y UN SURFACTANTE. OPCIONALMENTE, ESTAS COMPOSICIONES PUEDEN CONTENER SALES DE ALUMINIO Y UNO O MAS TAMPONES FARMACEUTICAMENTE ACEPTABLES.
ES96303930T 1995-06-02 1996-05-31 Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante. Expired - Lifetime ES2180703T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/459,602 US5690942A (en) 1995-06-02 1995-06-02 Adjuvants for viral vaccines
US459602 1995-06-02

Publications (2)

Publication Number Publication Date
ES2180703T3 true ES2180703T3 (es) 2003-02-16
ES2180703T5 ES2180703T5 (es) 2007-04-01

Family

ID=23825442

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96303930T Expired - Lifetime ES2180703T5 (es) 1995-06-02 1996-05-31 Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante.

Country Status (13)

Country Link
US (1) US5690942A (es)
EP (1) EP0745388B2 (es)
JP (1) JP4249807B2 (es)
KR (1) KR970000249A (es)
AT (1) ATE222504T1 (es)
AU (1) AU710499B2 (es)
CA (1) CA2177667C (es)
DE (1) DE69623072T3 (es)
DK (1) DK0745388T4 (es)
ES (1) ES2180703T5 (es)
HU (1) HUP9601462A2 (es)
NZ (1) NZ286700A (es)
PT (1) PT745388E (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
ZA997138B (en) * 1999-01-29 2001-05-16 Pfizer Prod Inc Erysipelothrix rhusiopathiae antigens and vaccine compositions.
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
AT407958B (de) * 1999-02-11 2001-07-25 Immuno Ag Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
US7632929B2 (en) * 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
AU2004226591B2 (en) * 2003-04-04 2009-06-04 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions
KR20110132416A (ko) 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
US9592277B2 (en) * 2004-04-14 2017-03-14 Avirid, Inc. Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
EP2140263B1 (en) * 2007-04-20 2017-01-04 The Board of Trustees of The University of Arkansas Hapten compounds and compositions and uses thereof
US20080292663A1 (en) * 2007-05-22 2008-11-27 Gerber Jay D Adjuvant compositions and methods for delivering vaccines
GB0801122D0 (en) * 2008-01-22 2008-02-27 Avecia Biolog Ltd Vaccine composition
AU2009299615B2 (en) 2008-10-02 2015-07-16 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
GB0917887D0 (en) * 2009-10-13 2009-11-25 Milan Guy D Temperature sensitive packaging closures
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN104208029B (zh) * 2013-05-30 2017-06-06 上海医药工业研究院 一种鼻用疫苗组合物粉体制剂及其制备方法
US10653766B2 (en) 2014-03-12 2020-05-19 Bavarian Nordic A/S Use of oil and water emulsions for increasing B cell responses with modified Vaccinia Ankara virus
KR20250110749A (ko) * 2024-01-12 2025-07-21 주식회사 티온랩테라퓨틱스 소르비탄 포화지방산을 포함하는 서방성 지질 전구 제제 및 이의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1163470A (en) * 1967-11-13 1969-09-04 Cecil Arthur Clark Improvements in or relating to Adjuvant Vaccines
US4466957A (en) * 1982-02-25 1984-08-21 American Home Products Corporation Vaccine adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US5376369A (en) * 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
FR2649013B1 (fr) † 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
FR2649012B1 (fr) † 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
WO1993024147A1 (en) † 1992-05-29 1993-12-09 Smithkline Beecham Corporation Lecithin adjuvanted modified live virus vaccines
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
US5690942A (en) 1997-11-25
DE69623072D1 (de) 2002-09-26
JP4249807B2 (ja) 2009-04-08
NZ286700A (en) 1997-10-24
DE69623072T3 (de) 2007-03-29
DE69623072T2 (de) 2002-12-19
DK0745388T4 (da) 2007-01-08
HU9601462D0 (en) 1996-07-29
CA2177667C (en) 2008-06-17
EP0745388B2 (en) 2006-08-30
DK0745388T3 (da) 2002-12-02
JPH08325162A (ja) 1996-12-10
EP0745388B1 (en) 2002-08-21
EP0745388A1 (en) 1996-12-04
AU5457496A (en) 1996-12-12
CA2177667A1 (en) 1996-12-03
ES2180703T5 (es) 2007-04-01
AU710499B2 (en) 1999-09-23
PT745388E (pt) 2002-11-29
ATE222504T1 (de) 2002-09-15
HUP9601462A2 (en) 1997-03-28
KR970000249A (ko) 1997-01-21

Similar Documents

Publication Publication Date Title
ES2180703T3 (es) Composiciones de vacunas para mamiferos que comprenden escualeno o escualano, un fosfolipido y un tensioactivo como adyuvante.
HN2002000153A (es) Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester.
ES2525418T3 (es) Composiciones farmacéuticas que comprenden cilostazol y un inhibidor de la recaptación de adenosina
UY27740A1 (es) Nuevos compuestos
ES2157447T3 (es) Composicion de vacuna que comprende un antigeno de polisacarido conjugado adsorbido en fosfato de aluminio.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
UY26776A1 (es) Inhibidores de 3-hidroxi-3-metilglutaril-coenzima a reductasa y métodos.
CR9609A (es) Formulaciones de una sal de bupropion de liberacion modificada
PA8521701A1 (es) Derivados de pirazol
PT1300398E (pt) Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
GT199700015A (es) Inhibidores de metaloproteinasa, composiciones farmaceuticas que las contienen y su uso farmaceutico y metodosyeficazproducto intermedio para su preparacion.
PA8517101A1 (es) Derivados de tropano ùtiles en terapia
ES2188177T3 (es) Composicion para la prevencion y/o el tratamiento de la osteoporosis y las alteraciones debidas al sindrome menopausico, que comprende propionil-l-carnitina y genisteina.
PA8567001A1 (es) Composicion de ziprasidona y controles sinteticos
ATE308341T1 (de) Pharmazeutische formulierungen
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
UY30460A1 (es) Compuestos terapéuticos
ATE284710T1 (de) Adjuvans für vitale impfstoffe
PA8426801A1 (es) Composiciones farmaceuticas para el tratamiento de la rinitis.
ES2109953T3 (es) 1,2,3,4-tetrahidrociclopent(b)indoles, 1,2,3,3a,4,8a-hexahidrociclopent(b)indoles sustituidos y compuestos relacionados, compuestos intermedios y un procedimiento para su preparacion y su uso como medicamentos.
UY27461A1 (es) Formas pseudopolimorficas de cardevilol.
AR021670A1 (es) UNA COMPOSICIoN QUE COMPRENDE 9-(2-((BIS(PIVALOILOXI)METIL)FOSFONO)METOXI)ETIL)ADENINA Y UN MÉTODO PARA SU PREPARACIoN
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
GT200100218A (es) Compuesto agroquimico.
ES2153875T3 (es) Agentes antitromboticos.